⚕ GalenOps CRO console
← 718 (USA)

718-1371

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 718 (USA) (Dr. Nolan) · consented 2013-04-26
Adverse events
6
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-24 (study day 29.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-24 (study day 29.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild FATIGUE — outcome: RECOVERED/RESOLVED; onset 2013-05-09 (study day 14.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate HALLUCINATION, VISUAL — outcome: RECOVERED/RESOLVED; onset 2013-06-02 (study day 38.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-05-09 (study day 14.0); relationship: POSSIBLE

severe serious reported 2026-08-18

Severe PARTIAL SEIZURES WITH SECONDARY GENERALISATION — outcome: RECOVERED/RESOLVED; onset 2013-06-02 (study day 38.0); relationship: NONE; serious criteria: hospitalization

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.